NASDAQ:VIVE Viveve Medical (VIVE) Stock Price, News & Analysis $0.0002 0.00 (0.00%) As of 10/9/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitors About Viveve Medical Stock (NASDAQ:VIVE) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Viveve Medical alerts:Sign Up Key Stats Today's Range$0.0002▼$0.000250-Day Range N/A52-Week Range$0.0001▼$0.0009Volume19 shsAverage Volume2,454 shsMarket Capitalization$434.00P/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Viveve Medical, Inc. was a women’s health company focused on developing and commercializing noninvasive treatments for vaginal health. Its principal product was the Viveve System, a medical device that used cryogen-cooled monopolar radiofrequency energy to heat and remodel tissue. The company promoted the system primarily for the treatment of vaginal laxity and related intimate-health concerns. The Viveve System was designed for use by healthcare professionals in office-based procedures and incorporated a disposable treatment tip. Viveve Medical sought regulatory clearances and commercial adoption in the United States and international markets, with distribution and clinical use reported in multiple countries. The company operated under the name Viveve, Inc. before adopting the Viveve Medical name. Publicly available information about its later operations, leadership, and current commercial activities is limited, and the company’s status and product availability may have changed since its period of public trading under the symbol VIVE.AI Generated. May Contain Errors. Read More Receive VIVE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. VIVE Stock News HeadlinesViveve Medical Inc.August 22, 2026 | marketwatch.comViveve Medical Inc (VIVE)July 24, 2024 | investing.comTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of Saudi Arabia's largest oil field, with potential to last two million years. While the One Big Beautiful Bill Act eliminated federal credits for solar, wind, and EVs, this energy source was reclassified alongside oil and nuclear power and given eight years of tax credits. Google signed a 15-year contract, and Bill Gates committed $100 million. One company controls the entire supply chain behind this discovery. | Behind the Markets (Ad)Incontinence Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key CompaniesJuly 19, 2024 | finance.yahoo.comVaginal Rejuvenation Is Big BusinessJuly 19, 2024 | ca.style.yahoo.com5-Alpha Reductase Deficiency Global Market Report 2024: A $1.94 Billion Projected Market in 2028April 17, 2024 | finance.yahoo.comInMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTLApril 15, 2024 | finance.yahoo.comVIVE Viveve Medical, Inc.July 29, 2023 | seekingalpha.comSee More Headlines VIVE Stock Analysis - Frequently Asked Questions How have VIVE shares performed this year? Viveve Medical's stock was trading at $0.0001 at the start of the year. Since then, VIVE shares have increased by 100.0% and is now trading at $0.0002. How were Viveve Medical's earnings last quarter? Viveve Medical, Inc. (NASDAQ:VIVE) released its quarterly earnings data on Thursday, November, 11th. The company reported ($0.67) earnings per share for the quarter, missing the consensus estimate of ($0.58) by $0.09. The firm had revenue of $1.62 million for the quarter. When did Viveve Medical IPO? Viveve Medical (VIVE) raised $13 million in an initial public offering (IPO) on Tuesday, June 14th 2016. The company issued 1,600,000 shares at $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager. How do I buy shares of Viveve Medical? Shares of VIVE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Viveve Medical own? Based on aggregate information from My MarketBeat watchlists, some other companies that Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), NIO (NIO) and Western Digital (WDC). Company Calendar Last Earnings11/11/2021Today10/12/2026Next Earnings (Estimated)11/13/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:VIVE Previous SymbolOTCMKTS:PLCSD CIK879682 Webwww.viveve.com Phone(720) 696-8100Fax720-696-8199Employees47Year Founded2005Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$6.83 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares2,170,000Free FloatN/AMarket Cap$434.00 OptionableNot Optionable Beta-0.16 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:VIVE) was last updated on 10/9/2026 by MarketBeat.com Staff. From Our PartnersPalantir and Wall Street are in on it…Palantir just signed a major AI deal with a company most investors have never heard of. Wall Street has pou...Monument Traders Alliance | SponsoredUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on p...Weiss Ratings | SponsoredFive Seats Could Shift Washington’s DirectionDemocrats need just five more seats to flip House control, with forecasts giving them a 61% to 85% chance ahea...USA Capital Gold | SponsoredI've seen this movie before (last time: 17,556%)My track record speaks for itself... KDA: 17,556%. PRE: 3,900%. OCEAN: 2,650%. Every single one was called ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Viveve Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Viveve Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VIVE Stock Alerts